These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 9643710)

  • 21. FDA: today's strengths built on turbulent past.
    Small WE
    Am Pharm; 1980 Jan; NS20(1):25-7. PubMed ID: 6989223
    [No Abstract]   [Full Text] [Related]  

  • 22. Review of the processes for FDA oversight of drugs, medical devices, and combination products.
    Sweet BV; Schwemm AK; Parsons DM
    J Manag Care Pharm; 2011; 17(1):40-50. PubMed ID: 21204589
    [No Abstract]   [Full Text] [Related]  

  • 23. New drug development.
    Taylor WJ
    Int Z Klin Pharmakol Ther Toxikol; 1969 Apr; 2(2):105-13. PubMed ID: 4895441
    [No Abstract]   [Full Text] [Related]  

  • 24. General considerations for studies of the metabolism of drugs and other chemicals.
    Glocklin VC
    Drug Metab Rev; 1982; 13(6):929-39. PubMed ID: 6754317
    [No Abstract]   [Full Text] [Related]  

  • 25. Submitting reports of adverse drug reactions to AJHP.
    Thompson CA
    Am J Hosp Pharm; 1994 Oct; 51(19):2358. PubMed ID: 7847399
    [No Abstract]   [Full Text] [Related]  

  • 26. Panel backs pain drug studies with new safety checks.
    Dolgin E
    Nat Med; 2012 Apr; 18(4):472. PubMed ID: 22481387
    [No Abstract]   [Full Text] [Related]  

  • 27. Adverse drug reactions, MedWatch reporting and medical student education.
    Lewis LD; Nierenberg DW
    Pharmacoepidemiol Drug Saf; 2003 Mar; 12(2):93-5. PubMed ID: 12642972
    [No Abstract]   [Full Text] [Related]  

  • 28. Historical overview of the safety of the food supply. Introduction.
    Darby WJ
    J Nutr; 1993 Feb; 123(2 Suppl):277-8. PubMed ID: 8429373
    [No Abstract]   [Full Text] [Related]  

  • 29. 'Drug reactions, enzymes, and biochemical genetics': 50 years later.
    Gurwitz D; Motulsky AG
    Pharmacogenomics; 2007 Nov; 8(11):1479-84. PubMed ID: 18034611
    [No Abstract]   [Full Text] [Related]  

  • 30. Sure cure: public policy on drug efficacy before 1962.
    Swann JP
    Publ Am Inst Hist Pharm; 1997; 16():223-61. PubMed ID: 11619897
    [No Abstract]   [Full Text] [Related]  

  • 31. Failing the public health--rofecoxib, Merck, and the FDA.
    Topol EJ
    N Engl J Med; 2004 Oct; 351(17):1707-9. PubMed ID: 15470193
    [No Abstract]   [Full Text] [Related]  

  • 32. U.S. postmarketing pharmacovigilance compliance in the midst of regulatory uncertainty.
    Goldman SA
    Food Drug Law J; 2007; 62(3):513-28. PubMed ID: 17915393
    [No Abstract]   [Full Text] [Related]  

  • 33. The history of disproportionality measures (reporting odds ratio, proportional reporting rates) in spontaneous reporting of adverse drug reactions.
    Moore N; Thiessard F; Begaud B
    Pharmacoepidemiol Drug Saf; 2005 Apr; 14(4):285-6. PubMed ID: 15782397
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug development history, "overview," and what are GCPs?
    Heilman RD
    Qual Assur; 1995 Mar; 4(1):75-9. PubMed ID: 8520867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The history of pharmacovigilance.
    Caron J; Rochoy M; Gaboriau L; Gautier S
    Therapie; 2016 Apr; 71(2):129-34. PubMed ID: 27080830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety profile of drugs for advanced melanoma: A report based on 2008-2018 US Food and Drug Administration Data.
    Casarotto E; Noize P; Létinier L; Salvo F; Pham-Ledard A; Molimard M
    Br J Clin Pharmacol; 2021 Jul; 87(7):2988-2995. PubMed ID: 33294983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A brief history of drug reactions.
    Laughlin S; Jackson R
    Clin Dermatol; 1986; 4(1):1-14. PubMed ID: 2978674
    [No Abstract]   [Full Text] [Related]  

  • 38. EUROmediCAT Recommendations for European Pharmacovigilance concerning safety of medication use in pregnancy.
    EUROmediCAT Steering Group
    Pharmacoepidemiol Drug Saf; 2015 Oct; 24 Suppl 2():3-7. PubMed ID: 26395593
    [No Abstract]   [Full Text] [Related]  

  • 39. [History of the development of US legislation to drugs].
    Utkin OB
    Farmatsiia; 1977; 26(4):78-82. PubMed ID: 332534
    [No Abstract]   [Full Text] [Related]  

  • 40. Advertising medicines sixty years ago.
    Turner P
    Postgrad Med J; 1985 Oct; 61(720):865-70. PubMed ID: 3903713
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.